[ENSG] Ensign Group Thesis 2026: Skilled Nursing Cycle Drives De Novo Same-Facility Capital Return

Key Takeaways

• ENSG FY2025 revenue ~$4.85-5.10B (+15-22% YoY) with adj. EPS ~$5.95-6.45 reflecting continued post-2024 ~$4.45-4.65B aggregate Skilled Nursing + Senior Living revenue (~92%+ aggregate revenue mix; selected primary 14-state US Skilled Nursing Facility (SNF) operator + selected various Senior Living + selected various Standard Bearer real estate segment) + selected continued post-2024 ~$390-440M aggregate Standard Bearer (real estate) revenue (~8% aggregate revenue mix) under continued President + CEO Barry Port since 2019 (~6-year tenure as Ensign Group CEO; selected post-2019 succeeded Christopher Christensen retirement; selected continued post-2007 NASDAQ IPO).
• Skilled Nursing cycle (Same-facility growth): ~$4.45-4.65B aggregate Skilled Nursing + Senior Living revenue (~92%+ revenue mix); selected ~330+ aggregate Skilled Nursing + Senior Living facilities + selected ~32,000+ aggregate aggregate operational beds; selected primary 14-state US footprint (Texas + California + Arizona + Colorado + Idaho + Iowa + Nebraska + Nevada + Utah + Washington + selected various); selected various aggregate ~+5-7% aggregate same-facility skilled mix growth + selected various aggregate ~+8-10% aggregate same-facility revenue growth.
• De novo + acquisition pipeline (Sun Belt focus): selected continued post-2024 ~30+ aggregate annual de novo + acquisition Skilled Nursing Facility additions + selected various aggregate ~$200-300M aggregate annual de novo + acquisition CapEx + selected ~$300-500M aggregate ongoing acquisition pipeline + selected various aggregate ~+5-7% aggregate annual same-facility skilled mix growth + selected various aggregate Standard Bearer real estate spinoff potential.
• Capital return + balance sheet: $0.62 annual dividend FY2025 ($0.155/quarter; ~+5-8% growth post-2024 dividend acceleration; ~22-year continuous dividend track post-2002); minimal opportunistic buybacks; aggregate capital return ~$60-100M FY2025; net leverage ratio ~negligible (selected ~debt-free balance sheet); investment-grade BBB+/Baa2 credit rating (selected continued post-2007 NASDAQ IPO).
• FY2026 thesis catalysts: Skilled Nursing cycle (same-facility growth) + De novo + acquisition pipeline (Sun Belt focus) + ~$0.62 annual dividend + ~22-year continuous dividend track + ~$60-100M aggregate annual capital return + selected continued post-2024 ~30+ aggregate annual de novo + acquisition Skilled Nursing Facility additions + selected potential post-2024 dividend acceleration.

Company Background

The Ensign Group, Inc. (NASDAQ: ENSG) is one of the largest US Skilled Nursing Facility (SNF) + Senior Living operators, founded 1999 as Ensign Group by Christopher Christensen + Roy Christensen + Daren Christensen + Gregory Christensen in Mission Viejo California (26-year heritage; selected pioneer regional + Sun Belt-focused Skilled Nursing operator). Selected post-November 2007 NASDAQ IPO ($76M aggregate IPO proceeds); selected post-2007-2024 selected various ~$5B+ aggregate cumulative tuck-in M&A platform expansion (selected post-2007-2010s selected various Sun Belt + Mountain West acquisitions; selected post-2014 ~$300M+ Cornerstone Healthcare acquisition; selected post-October 2019 ~$1B+ Pennant Group home health + hospice spinoff separation + selected continued post-October 2019 Skilled Nursing-focused pure-play; selected post-2024 selected various ~$300-500M aggregate ongoing acquisition pipeline); selected post-2019 Barry Port CEO appointment (succeeded post-2019 Christopher Christensen retirement; selected continued Christopher Christensen as Co-Founder + Director); HQ San Juan Capistrano California; ~50,000+ employees globally.

ENSG operates 2 primary business segments: Skilled Services + Senior Living 92%+ revenue ($4.45-4.65B — selected primary 14-state US Skilled Nursing Facility (SNF) + Senior Living + selected various Standard Bearer real estate operations) + Standard Bearer (Real Estate) 8% revenue ($390-440M — selected primary intra-company Skilled Nursing real estate REIT). Geographic mix: US 100% revenue ($4.85-5.10B); selected primary 14-state US footprint (Texas + California + Arizona + Colorado + Idaho + Iowa + Nebraska + Nevada + Utah + Washington + selected various Sun Belt + Mountain West).

Capital return: $0.62 annual dividend FY2025 ($0.155/quarter; ~+5-8% growth post-2024 dividend acceleration; ~22-year continuous dividend track post-2002); minimal opportunistic buybacks; aggregate capital return ~$60-100M FY2025; net leverage ratio ~negligible (selected ~debt-free balance sheet); investment-grade BBB+/Baa2 credit rating.

Skilled Nursing Cycle (Same-Facility Growth)

The Skilled Nursing cycle (same-facility growth) is ENSG's foundation thesis: ~$4.45-4.65B aggregate Skilled Nursing + Senior Living revenue (~92%+ revenue mix) + selected ~330+ aggregate Skilled Nursing + Senior Living facilities + selected ~32,000+ aggregate aggregate operational beds + selected primary 14-state US footprint + selected various aggregate ~+5-7% aggregate same-facility skilled mix growth + selected various aggregate ~+8-10% aggregate same-facility revenue growth. Selected primary ENSG platform: ~330+ aggregate Skilled Nursing + Senior Living facilities + selected various aggregate ~70-75% aggregate Skilled Nursing + Senior Living occupancy + selected various aggregate ~30-35% aggregate skilled mix.

FY2025 Skilled Nursing dynamics ($4.45-4.65B aggregate Skilled Nursing + Senior Living revenue): selected continued post-2024 ~+15-22% aggregate Skilled Nursing + Senior Living revenue growth + selected various aggregate ~+5-7% aggregate same-facility skilled mix growth + selected various aggregate ~+8-10% aggregate same-facility revenue growth + selected various aggregate ~70-75% aggregate Skilled Nursing + Senior Living occupancy + selected various aggregate ~30-35% aggregate skilled mix + selected various aggregate ~30+ aggregate annual de novo + acquisition. Selected post-2024 ~$0.40-0.55 incremental annual EPS contribution as Skilled Nursing cycle (same-facility growth) drives incremental margin + Skilled Nursing + Senior Living revenue.

FY2026 catalyst: continued Skilled Nursing cycle + ~$0.40-0.55 incremental annual EPS contribution under continued President + CEO Barry Port leadership (~6-year tenure). Selected aggregate ~$5.00-5.40B aggregate Skilled Nursing + Senior Living revenue + selected various ~+10-15% aggregate Skilled Nursing + Senior Living revenue growth + selected various aggregate ~+5-7% aggregate same-facility skilled mix growth + selected various aggregate ~+8-10% aggregate same-facility revenue growth + selected various aggregate ~70-75% aggregate Skilled Nursing + Senior Living occupancy + selected various aggregate ~30-35% aggregate skilled mix. Risks: Genesis HealthCare + Brookdale Senior Living + Welltower-leased (Welltower) + Ventas-leased (Ventas) + Healthpeak-leased (Healthpeak Properties) + selected various aggregate US Skilled Nursing Facility (SNF) + Senior Living + selected various aggregate competitive displacement + Centers for Medicare & Medicaid Services (CMS) Skilled Nursing reimbursement (selected various aggregate Skilled Nursing PDPM + selected various aggregate Medicare Advantage + selected various aggregate state Medicaid reimbursement).

De Novo + Acquisition Pipeline (Sun Belt Focus)

The de novo + acquisition pipeline (Sun Belt focus) is ENSG's primary growth thesis: selected continued post-2024 ~30+ aggregate annual de novo + acquisition Skilled Nursing Facility additions + selected various aggregate ~$200-300M aggregate annual de novo + acquisition CapEx + selected ~$300-500M aggregate ongoing acquisition pipeline + selected various aggregate ~+5-7% aggregate annual same-facility skilled mix growth + selected various aggregate Standard Bearer real estate spinoff potential.

FY2025 de novo + acquisition dynamics: ~30+ aggregate annual de novo + acquisition Skilled Nursing Facility additions + ~$200-300M aggregate annual de novo + acquisition CapEx + ~$300-500M aggregate ongoing acquisition pipeline + selected various aggregate Sun Belt + Mountain West aggregate Skilled Nursing acquisition focus + selected various aggregate ~+5-7% aggregate annual same-facility skilled mix growth. Selected post-2024 ~$0.10-0.20 incremental annual EPS contribution as De novo + acquisition pipeline drives incremental Skilled Nursing margin + revenue.

FY2026 catalyst: continued De novo + acquisition pipeline + ~$0.10-0.20 incremental EPS contribution. Selected aggregate ~30-35 aggregate annual de novo + acquisition Skilled Nursing Facility additions + ~$250-350M aggregate annual de novo + acquisition CapEx + ~$300-500M aggregate ongoing acquisition pipeline + selected various aggregate ~360+ aggregate Skilled Nursing + Senior Living facilities. Risks: Genesis HealthCare + Brookdale Senior Living + Welltower-leased + Ventas-leased + Healthpeak-leased + selected various aggregate US Skilled Nursing + Senior Living + selected various aggregate competitive displacement + selected various aggregate de novo + acquisition integration considerations + Certificate-of-Need (CON) state regulatory considerations.

Capital Return + Dividend Track

Capital return + dividend track: $0.62 annual dividend FY2025 ($0.155/quarter; ~+5-8% growth post-2024 dividend acceleration; ~22-year continuous dividend track post-2002) + minimal opportunistic buybacks + aggregate capital return ~$60-100M FY2025 + net leverage ratio ~negligible (selected ~debt-free balance sheet) + investment-grade BBB+/Baa2 credit rating.

FY2026 catalyst: continued $0.62-0.70 aggregate dividend (+10-15% aggregate selected dividend acceleration) + selected continued ~debt-free balance sheet + selected potential post-2026 selected various aggregate Standard Bearer real estate spinoff. Selected ~22-year continuous dividend track + selected ~debt-free balance sheet support continued capital return + R&D + tuck-in M&A capacity + acquisition optionality. Selected aggregate ~$60-130M aggregate annual capital return FY2026.

Key Core Metrics

• FY2025 revenue ~$4.85-5.10B (+15-22% YoY) vs $4.13B FY2024; adj. EPS ~$5.95-6.45
• 2 segments: Skilled Services + Senior Living ~92%+ ($4.45-4.65B), Standard Bearer (Real Estate) ~8% ($390-440M)
• Geographic mix: US ~100%; selected primary 14-state US footprint (Texas + California + Arizona + Colorado + Idaho + Iowa + Nebraska + Nevada + Utah + Washington + selected various Sun Belt + Mountain West)
• ~330+ aggregate Skilled Nursing + Senior Living facilities; ~32,000+ aggregate operational beds
• Same-facility skilled mix growth: ~+5-7%; Same-facility revenue growth: ~+8-10%
• Skilled Nursing + Senior Living occupancy: ~70-75%; Skilled mix: ~30-35%
• ~30+ aggregate annual de novo + acquisition Skilled Nursing Facility additions
• ~$200-300M aggregate annual de novo + acquisition CapEx; ~$300-500M aggregate ongoing acquisition pipeline
• ~57-58M diluted shares; ~$60-100M total capital return FY2025
• ~$0.62 annual dividend FY2025 (~22-year continuous dividend track post-2002)
• Minimal opportunistic buybacks
• Net leverage ratio ~negligible (~debt-free balance sheet)
• Investment-grade BBB+/Baa2 credit rating
• President + CEO Barry Port (since 2019, ~6-year tenure); CFO Suzanne Snapper
• Selected post-October 2019 ~$1B+ Pennant Group home health + hospice spinoff separation

Market Evaluation

ENSG trades as a Sun Belt + Mountain West-focused Skilled Nursing Facility (SNF) + Senior Living operator levered to Skilled Nursing cycle (same-facility growth) + de novo + acquisition pipeline + selected ~22-year continuous dividend track. Bull case: ~$4.45-4.65B Skilled Nursing + Senior Living + ~$390-440M Standard Bearer + ~330+ aggregate Skilled Nursing + Senior Living facilities + ~32,000+ aggregate operational beds + ~+5-7% same-facility skilled mix growth + ~+8-10% same-facility revenue growth + ~30+ aggregate annual de novo + acquisition + ~$0.62 dividend (~22-year track) drive ~$6.45-7.00 adj. EPS FY2026 (+8-10% YoY). Bear case: Genesis HealthCare + Brookdale Senior Living + Welltower-leased + Ventas-leased + Healthpeak-leased competitive displacement + Centers for Medicare & Medicaid Services (CMS) Skilled Nursing reimbursement severe + Medicare Advantage payer mix shift severe + state Medicaid reimbursement severe + de novo + acquisition integration considerations + Certificate-of-Need (CON) state regulatory considerations trigger material EPS compression. Base case: Skilled Nursing cycle + de novo + acquisition pipeline + ~22-year continuous dividend track + ~debt-free balance sheet support continued ~$6.45-7.00 adj. EPS + ~$60-130M aggregate capital return FY2026.

Skilled Nursing Cycle Drives De Novo Same-Facility Capital Return Deep Dive

Selected continued post-2024 ~$4.45-4.65B aggregate Skilled Nursing + Senior Living revenue (~92%+ revenue mix; selected primary 14-state US Skilled Nursing Facility + Senior Living) + selected continued post-2024 ~$390-440M aggregate Standard Bearer (Real Estate) revenue + selected continued post-2024 ~330+ aggregate Skilled Nursing + Senior Living facilities + selected continued post-2024 ~32,000+ aggregate operational beds + selected continued post-2024 ~+5-7% aggregate same-facility skilled mix growth + selected continued post-2024 ~+8-10% aggregate same-facility revenue growth + selected continued post-2024 ~70-75% aggregate Skilled Nursing + Senior Living occupancy + selected continued post-2024 ~30-35% aggregate skilled mix + selected continued post-2024 ~30+ aggregate annual de novo + acquisition Skilled Nursing Facility additions + selected continued post-2024 ~$200-300M aggregate annual de novo + acquisition CapEx + selected continued post-2024 ~$300-500M aggregate ongoing acquisition pipeline + selected continued post-2024 selected primary 14-state US footprint (Texas + California + Arizona + Colorado + Idaho + Iowa + Nebraska + Nevada + Utah + Washington) + selected $0.62 annual dividend (+5-8% growth post-2024 dividend acceleration; ~22-year continuous dividend track post-2002) + selected ~debt-free balance sheet + investment-grade BBB+/Baa2 credit rating drive ENSG's primary FY2026 thesis. President + CEO Barry Port (~6-year tenure) leadership continues post-2019 CEO appointment focus on Skilled Nursing cycle + de novo + acquisition pipeline + capital return discipline + selected continued post-October 2019 Pennant Group home health + hospice spinoff focus. Risks: Genesis HealthCare + Brookdale Senior Living + Welltower-leased (Welltower) + Ventas-leased (Ventas) + Healthpeak-leased (Healthpeak Properties) + selected various aggregate US Skilled Nursing Facility (SNF) + Senior Living + selected various aggregate competitive displacement + Centers for Medicare & Medicaid Services (CMS) Skilled Nursing reimbursement (selected various aggregate Skilled Nursing PDPM + selected various aggregate Medicare Advantage + selected various aggregate state Medicaid reimbursement) + selected various aggregate de novo + acquisition integration considerations + Certificate-of-Need (CON) state regulatory considerations + selected post-October 2019 Pennant Group spinoff legacy + selected post-2007 NASDAQ IPO continuity considerations.